In order to determine the value of the Ube3a deficient mouse as a model for Angelman syndrome it will be important to understand whether the phenotypic differences between patients and Ube3a deficient mice reported here are based on species specific effects of loss of Ube3a expression, on differences in the extent of the genetic defects or on a combination of both. This evidence concerns the gene UBE3A and Angelman syndrome.